3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Head and Neck Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Multiple Myeloma
3
Lymphoma
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Cancers of the Head and Neck
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Mouth Neoplasms
1
Glioma
1
Fanconi Anemia
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Interventions
Nivolumab
4
Ipilimumab
3
Specimen Handling
2
Proton Therapy
2
Magnetic Resonance Spectroscopy
2
Cetuximab
2
tazemetostat
1
spartalizumab
1
pembrolizumab
1
nilotinib
1
atezolizumab
1
Zoledronic Acid
1
X-Rays
1
Tiragolumab
1
Surveys and Questionnaires
1
Radiotherapy
1
Radiosurgery
1
Phantoms, Imaging
1
Imatinib Mesylate
1
Fluorodeoxyglucose F18
1
Cyclophosphamide
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Chordoma
×
Afatinib
×
1 year
×
Clear all
No trials found.